Lucid Diagnostics (Lucid Diagnostics) Days Inventory : 14.66 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lucid Diagnostics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Lucid Diagnostics's Average Total Inventories for the three months ended in Dec. 2023 was $0.23 Mil. Lucid Diagnostics's Cost of Goods Sold for the three months ended in Dec. 2023 was $1.46 Mil. Hence, Lucid Diagnostics's Days Inventory for the three months ended in Dec. 2023 was 14.66.

The historical rank and industry rank for Lucid Diagnostics's Days Inventory or its related term are showing as below:

LUCD' s Days Inventory Range Over the Past 10 Years
Min: 8.34 Med: 30.5 Max: 413.98
Current: 8.34

During the past 5 years, Lucid Diagnostics's highest Days Inventory was 413.98. The lowest was 8.34. And the median was 30.50.

LUCD's Days Inventory is ranked better than
99.48% of 776 companies
in the Medical Devices & Instruments industry
Industry Median: 188.435 vs LUCD: 8.34

Lucid Diagnostics's Days Inventory increased from Dec. 2022 (6.06) to Dec. 2023 (14.66). It might indicate that Lucid Diagnostics's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Lucid Diagnostics's Inventory Turnover for the three months ended in Dec. 2023 was 6.23.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lucid Diagnostics's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.23.

Lucid Diagnostics Days Inventory Historical Data

The historical data trend for Lucid Diagnostics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lucid Diagnostics Days Inventory Chart

Lucid Diagnostics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

413.98

30.50

11.87

Lucid Diagnostics Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial											6.06	5.90	3.06	6.48	14.66

Competitive Comparison of Lucid Diagnostics's Days Inventory

For the Medical Devices subindustry, Lucid Diagnostics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lucid Diagnostics's Days Inventory Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lucid Diagnostics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Lucid Diagnostics's Days Inventory falls into.

Lucid Diagnostics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lucid Diagnostics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.111	+	0.278)	/	2 )	/	5.979	*	365
=	0.1945					/	5.979	*	365
=	11.87

Lucid Diagnostics's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.19	+	0.278)	/	2 )	/	1.457	*	365 / 4
=	0.234					/	1.457	*	365 / 4
=	14.66

Lucid Diagnostics (NAS:LUCD) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lucid Diagnostics's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.457	/	0.234
	=	6.23

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lucid Diagnostics's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.234	/	1.04
	=	0.23

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Lucid Diagnostics Days Inventory Related Terms

Thank you for viewing the detailed overview of Lucid Diagnostics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Lucid Diagnostics (Lucid Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lucid Diagnostics Inc (NAS:LUCD) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

360 Madison Avenue, 25th Floor, New York, NY, USA, 10017

Website

https://www.luciddx.com

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Executives

Stanley Lapidus	director	101 HARTWELL AVE., LEXINGTON MA 02421
Debra White	director	C/O PAVMED INC., ONE GRAND CENTRAL PLACE, SUITE 4600, NEW YORK NY 10165
Michael Adam Gordon	officer: General Counsel	ONE GRAND CENTRAL PLACE, SUITE 4600, NEW YORK NY 10165
Shaun O'neil	officer: Chief Operating Officer	ONE GRAND CENTRAL PLACE, SUITE 4600, NEW YORK NY 10165
Pavmed Inc.	10 percent owner	360 MADISON AVENUE, 25TH FLOOR, NEW YORK NY 10017
Lishan Aklog	director, officer: Chief Executive Officer	420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10171
Dennis M Mcgrath	officer: Chief Financial Officer	C/O PAVMED INC., ONE GRAND CENTRAL PLACE, STE. 4600, NEW YORK NY 10165
Ronald M Sparks	director	420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10170
James L Cox	director	420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10170
Aster Angagaw	director	150 PEABODY PLACE, MEMPHIS TN 38103
Jacque J Sokolov	director
David F Wurtman	officer: Chief Medical Officer	ONE GRAND CENTRAL PLACE, SUITE 4600, NEW YORK NY 10165